FdaApplication
NDA 213973
Identifiers
- fda_app_no: NDA213973
Properties
| Property | Value |
|---|---|
| applicant_name | DECIPHERA PHARMACEUTICALS LLC |
| application_type | NDA |
| approval_date | 2020-05-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| QINLOCK | RIPRETINIB | 50MG | TABLET;ORAL |
1 product